Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
The Senior Director, Head of Patient Services will lead the design, implementation, and ongoing management of Capricor's U.S. patient services organization in support of the anticipated launch of deramiocel, Capricor's lead cell therapy for Duchenne muscular dystrophy. This leader will establish a high-touch, compliant, and scalable support model that helps patients, caregivers, healthcare providers, and treatment centers navigate access, affordability, and treatment initiation. This is a hands-on launch leadership role with end-to-end accountability for patient services strategy, hub operations, affordability programs, site-of-care coordination, vendor performance, data and reporting, and team development. The position will partner closely with Market Access, Trade and Distribution, Commercial Operations, Finance, Medical, Quality, IT, Legal, and Compliance, as well as external hub, specialty pharmacy, distribution, and treatment-center partners.